SUGALIFE-D 10/60 - Dapagliflozin 10 mg + Gliclazide 60 mg (SR) | Intralife Pharmaceuticals
DIASAGE
Top

SUGALIFE-D 10/60

MRP: 1,570

Packaging: 10X10

Pack Type: tablet

Composition:

Dapagliflozin 10 mg + Gliclazide 60 mg (SR)

Indication:

Used for the management of Type 2 Diabetes Mellitus in adults to help control blood sugar levels. It combines Dapagliflozin (an SGLT2 inhibitor) and Gliclazide (a sulfonylurea) for improved glycemic control when diet, exercise, and monotherapy are not sufficient.

Description:

This combination of Dapagliflozin and Gliclazide SR is designed for effective management of Type 2 Diabetes Mellitus in adults. It combines the benefits of two powerful glucose-lowering mechanisms:

  • Dapagliflozin promotes urinary glucose excretion by inhibiting sodium-glucose co-transporter-2 (SGLT2) in the kidneys.

  • Gliclazide, a sulfonylurea, stimulates insulin release from pancreatic beta cells.

Together, they offer comprehensive glycemic control, reducing both fasting and postprandial blood sugar, while offering weight neutrality or reduction and cardiovascular benefits associated with Dapagliflozin.

Tags:

Antidiabetic Type 2 Diabetes SGLT2 Inhibitor Sulfonylurea Oral Hypoglycemics Blood Sugar Control Weight-Friendly Cardiometabolic Health
  • Dapagliflozin has shown benefits in heart failure and early kidney disease but always consult your doctor.
  • Reduces HbA1c levels significantly
  • May aid weight loss or weight neutrality
  • Cardiovascular and renal protective effects from Dapagliflozin
  • Convenient once-daily dosing
  • Sustained-release Gliclazide provides longer blood sugar coverage

Usage Information

Dosage

Usual Dose: 1 tablet once daily, preferably in the morning Take with or after breakfast Do not crush or chew the tablet Follow the physician's dosage based on blood glucose response Regular sugar level monitoring is essential

Side Effects

Hypoglycemia (especially if meals are skipped) Frequent urination or urinary tract infections Dizziness or dehydration Thirst or dry mouth Genital fungal infections (rare) Headache, fatigue

Contraindications

Type 1 Diabetes or diabetic ketoacidosis Severe renal impairment History of recurrent urinary tract infections Hypersensitivity to sulfonylureas or SGLT2 inhibitors Pregnancy and breastfeeding (unless prescribed) Severe liver dysfunction

Availability

Dapagliflozin Gliclazide tablets, Dapagliflozin 10mg, Gliclazide SR 60mg, SGLT2 inhibitor sulfonylurea combo, diabetes type 2 dual therapy, blood sugar control tablets, Dapagliflozin with Gliclazide, diabetic sugar medicine, combination diabetes tablets, weight-loss diabetes medicine